---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-014316"
form_type: "8-K/A"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:31:35.014320+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics still not in compliance with Nasdaq minimum bid price; requests extension

## Summary
- Received Nasdaq deficiency letter on Sept 6, 2023 for bid price below $1.00 for 30 consecutive business days.
- Stock traded above $1.00 for 14 consecutive days Jan 19-Feb 7, 2024, but Nasdaq has not confirmed compliance.
- Company intends to request an additional 180-day compliance period under Nasdaq rules.
- If compliance not regained, delisting notice would trigger a hearing; reverse stock split considered as option.

## SEC filing metadata
- accession: 0001213900-24-014316
- form_type: 8-K/A
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390024014316/0001213900-24-014316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390024014316/ea193846-8ka1_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-014316
- JSON: https://secwatch.observer/filing/0001213900-24-014316.json
- Plain text: https://secwatch.observer/filing/0001213900-24-014316.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.